AU6246394A - Use of heparin to inhibit interleukin-8 - Google Patents
Use of heparin to inhibit interleukin-8Info
- Publication number
- AU6246394A AU6246394A AU62463/94A AU6246394A AU6246394A AU 6246394 A AU6246394 A AU 6246394A AU 62463/94 A AU62463/94 A AU 62463/94A AU 6246394 A AU6246394 A AU 6246394A AU 6246394 A AU6246394 A AU 6246394A
- Authority
- AU
- Australia
- Prior art keywords
- heparin
- inhibit interleukin
- interleukin
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 title 1
- 108090001007 Interleukin-8 Proteins 0.000 title 1
- 229960002897 heparin Drugs 0.000 title 1
- 229920000669 heparin Polymers 0.000 title 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 title 1
- 229940096397 interleukin-8 Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2078993A | 1993-02-22 | 1993-02-22 | |
| US020789 | 1993-02-22 | ||
| PCT/US1994/001864 WO1994018989A1 (en) | 1993-02-22 | 1994-02-22 | Use of heparin to inhibit interleukin-8 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6246394A true AU6246394A (en) | 1994-09-14 |
Family
ID=21800591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62463/94A Abandoned AU6246394A (en) | 1993-02-22 | 1994-02-22 | Use of heparin to inhibit interleukin-8 |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6246394A (en) |
| WO (1) | WO1994018989A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
| US5801168A (en) * | 1994-06-09 | 1998-09-01 | Zeneca Limited | Substituted nitrogen heterocycles |
| DE69621528T2 (en) * | 1995-02-07 | 2003-01-16 | Shiseido Co. Ltd., Tokio/Tokyo | ANTI-INFLAMATIVE AGENTS |
| US6497878B1 (en) * | 1996-04-23 | 2002-12-24 | Chugai Seiyaku Kabushiki Kaisha | Treatment of cerebral disorders by inhibition of IL-8 binding to receptor |
| GB2333450A (en) * | 1998-01-23 | 1999-07-28 | Marshtech International Ltd | Anti-Snoring Compositions |
| KR102165348B1 (en) | 2012-05-09 | 2020-10-14 | 캔텍스 파마슈티칼즈, 인크. | Treatment of myelosuppression |
| EP3258941A4 (en) | 2015-02-17 | 2018-09-26 | Cantex Pharmaceuticals, Inc. | Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction |
| WO2022128054A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4679555A (en) * | 1984-08-07 | 1987-07-14 | Key Pharmaceuticals, Inc. | Method and apparatus for intrapulmonary delivery of heparin |
| SU1544433A1 (en) * | 1988-05-10 | 1990-02-23 | Благовещенский государственный медицинский институт | Method of treating respiratory dificiency of nonspecific pulmonary disease patients |
| PT1164145E (en) * | 1992-07-24 | 2008-03-17 | Paringenix Inc | Non-anticoagulant desulfated heparins as medicaments |
-
1994
- 1994-02-22 WO PCT/US1994/001864 patent/WO1994018989A1/en not_active Ceased
- 1994-02-22 AU AU62463/94A patent/AU6246394A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994018989A1 (en) | 1994-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2975892A (en) | Methods of damping | |
| AU1742695A (en) | Production and use of 2-o-desulfated heparin to inhibit elastase | |
| AU5616994A (en) | Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation | |
| AU7867994A (en) | Hemofiltration of mediator-related diseases | |
| EP1878827B8 (en) | Implementation of dissolved solids profiling | |
| AU1608892A (en) | Use of acetals | |
| AU652321B1 (en) | Purification of pentafluoroethane | |
| AU4772493A (en) | Sulfo-derivatives of adenosine | |
| AU3476889A (en) | Anti-vibration leg unit | |
| AU6246394A (en) | Use of heparin to inhibit interleukin-8 | |
| AU4224096A (en) | Use of phenylcyclohexylcarboxamides | |
| AU8119594A (en) | Use of low anticoagulant heparinderivatives | |
| AU6723294A (en) | Use of simmondsine | |
| AU6397794A (en) | Use of platelet factor 4 to treat inflammatory diseases | |
| AU4104889A (en) | Purification of erythropoietin | |
| AU6377294A (en) | Use of ferrocene | |
| AU5371694A (en) | Use of the tarchonanthus camphoratus | |
| AU6357890A (en) | Expression of alpha-macroglobulins | |
| AU5200293A (en) | Improvements in or relating to the movement of members | |
| AU7191498A (en) | Cessation of tobacco use | |
| AU8155194A (en) | Methods of increasing macrophage function | |
| AU1414292A (en) | Determination of contaminants | |
| AU5861690A (en) | Use of retinoids | |
| AU1049895A (en) | Methods relating to ir-95 | |
| AU4041493A (en) | Shuttlecock of various uses |